Psychiatric Disorders and Montelukast in Children: A Disproportionality Analysis of the VigiBase(®).
Ana Aldea PeronaMar García-SáizEmílio J SanzPublished in: Drug safety (2016)
Neuropsychiatric disorders as side effects of montelukast were more frequently reported for children than for adults. Infants and children seem to be more prone to sleep disturbances, whereas adolescents present symptoms of depression/anxiety and psychotic reactions more often. Suicidal behaviour and completed suicide appear to be more frequently reported than previously thought in practice. Risk management plans and epidemiological studies are needed to quantify the risk. Practitioners should be aware of the risk of neuropsychiatric events associated with montelukast use, and should advise the patient and report new cases.